Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.5.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.1.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.15.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.9.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FA.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
ER.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CQ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.13NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XMNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.70NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.63NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.4.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.8.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EC.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XLNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.87 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.23.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XNNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.111 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.31NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CG.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.2.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.20NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.30NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.7.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EA.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.2.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DH.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XGNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
C.37 (Lambda)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.14 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.7.1 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
P.1.2 (Gamma)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.112 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used